Navigation Links
Harvard Scientists Commend Erchonia for Excellence in Clinical Research for the Zerona Laser
Date:8/6/2013

McKinney, TX (PRWEB) August 06, 2013

In the latest volume of the medical journal, Lasers in Surgery and Medicine, three Harvard scientists reviewed the merits of laser therapy for body contouring and concluded that Erchonia’s research for its Zerona low-level laser device has, "set the precedent on how aesthetic devices should be evaluated." One of the article’s authors, Michael Hamblin, PhD., is recognized as the world’s leading expert in low level laser therapy, making the praise all the more significant.

Zerona was the first noninvasive aesthetic device to receive FDA market clearance in the U.S. for circumferential reduction of the waist, hips and thighs. Erchonia tested the Zerona laser using a placebo-controlled, randomized, double blind, multisite clinical investigation evaluating 67 study participants. The patients treated with the Zerona laser experienced an average reduction of 3.51 inches across the waist, hips and thighs in just two weeks.

The article praised Erchonia’s clinical approach for Zerona, noting, "The clinical trial absence of diet restrictions, exercise requirements or any other adjunctive components properly illustrated the clinical utility of the Zerona and set the precedent on how aesthetic devices should be evaluated."

Steven Shanks, president of Erchonia comments, "Having an expert such as Dr. Hamblin recognize the quality of our research and the clinical utility of Erchonia’s Zerona laser is truly an honor. For a small medical device manufacturer like Erchonia, quality clinical research is pivotal for our overall success. Erchonia’s research stands out in aesthetic medicine because more and more devices, such as Erchonia’s competitors, such as fat-freezing devices, are tested in non-randomized, non-controlled clinical trials."

This is not the first time an independent review recognized the clinical utility of Zerona. An article published in Clinics in Plastic Surgery in 2011 stated, "Zerona is in a unique and beneficial category as it exemplifies a truly non-invasive approach, inducing slimming without cell death or upregulation of inflammation."

For more information, please visit http://www.erchonia.com or http://www.myzerona.com.

About Erchonia

Erchonia is the global leader in low level laser healthcare applications. Over the last 15 years, Erchonia has been conducting research and development with the world’s leading physicians to advance the science of low level lasers. Prior to market introduction, all Erchonia lasers are proven safe and effective through independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat, eliminate pain, and treat acne. For additional information, visit http://www.erchonia.com.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10999754.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. How To Break the Sugar Habit, from the July 2013 Harvard Women's Health Watch
2. A Checklist for Heart Attack Prevention, from the July 2013 Harvard Men's Health Watch
3. Blueberries, Strawberries Protect the Heart, from the July 2013 Harvard Heart Letter
4. Nutrition in a Bottle: Sometimes More Hype Than Help, from the July 2013 Harvard Health Letter
5. Believing Myths and Misconceptions About Heart Disease May Increase Heart Attack Risk, from the June 2013 Harvard Heart Letter
6. Simple Steps for Boosting Energy, from the June 2013 Harvard Men's Health Watch
7. Joint surgery isn't the First Option for Knee and Hip Arthritis, from the June 2013 Harvard Health Letter
8. Science news from Harvard Stem Cell Institute
9. Bel Marra Health Reports on a New Harvard Study: Abuse of Prescription Drugs and Alcohol on the Steady Upswing
10. Diet Can Lower Blood Pressure As Much As Taking A Medication, From The March 2013 Harvard Men's Health Watch
11. Zinga! Frozen Yogurt Touts Harvard Study for National Nutrition Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... surgery as possible. With this in mind, SIGVARIS has created a new line ... clot) during bed rest and provide the benefits of graduated compression when transitioning ...
(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the digital ... B led by Canvas Ventures . Other investors include Nokia Growth Partners (NGP) ... platform to serve more consumers who are managing chronic conditions or simply ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... planning services from offices headquartered in Hamilton County, is embarking on a charity ... LuvFurMutts specializes in finding new homes for orphaned or neglected senior dogs in ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp ... in and around the greater Phoenix metropolitan region, is announcing a charity event ... mission of the Homeless Youth Connection is to promote community awareness of the ...
(Date:12/8/2016)... Bay St. Louis, MS (PRWEB) , ... December 08, 2016 , ... ... with offices that serve commercial and residential clients in and around the Hancock County ... community support for the Hancock County Food Pantry. , The Hancock County Food Pantry ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- Boehringer Ingelheim announced today that it has been recognized ... the ninth time that the company received a perfect ... to Work for LGBT Equality. Administered by the Human ... report on corporate policies and practices related to workplace ... "We are committed to creating an ...
(Date:12/8/2016)... December 8, 2016 According ... Market by Product (Actual Sugars, Sugar Alcohols, Artificial ... Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) - ... market has witnessed healthy growth during the last ... CAGR of 4.3% between 2016 and 2021 to ...
(Date:12/8/2016)... According to a new market research report "Wearable Medical Devices ... End Use (Sports, Fitness, RPM), Type (Smart watch, Patch), Distribution Channel (Pharmacy, ... terms of value, is projected to reach 12.14 Billion by 2021 from ... forecast period. Continue Reading ... ...
Breaking Medicine Technology: